Cargando…

Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights

Prognostic markers, such as NPM1, Flt3-ITD, and cytogenetic abnormalities have made it possible to formulate aggressive treatment plans for unfavorable acute myeloid leukemia (AML). However, the long-term survival of AML with unfavorable factors remains unsatisfactory. The latest data indicate that...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiongpeng, Ma, Yuehua, Liu, Delong
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880983/
https://www.ncbi.nlm.nih.gov/pubmed/20416083
http://dx.doi.org/10.1186/1756-8722-3-17